$20.61
+0 (+0%)
At Close: Oct 23, 2025
NEW YORK, NY / ACCESS Newswire / January 24, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ:EPIX) and certain offi
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ESSA Bancorp
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of ESSA Bancorp, Inc. - ESSA
03:00pm, Friday, 10'th Jan 2025
NEW YORK , Jan. 10, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securit
Shareholder Alert: Ademi LLP investigates whether ESSA Bancorp, Inc. is obtaining a Fair Price for its Public Shareholders
10:37am, Friday, 10'th Jan 2025
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating ESSA Bancorp (NASDAQ: ESSA) for possible breaches of fiduciary duty and other violations of law in its transaction with CNB Financial. Click here
ESSA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ESSA Bancorp, Inc. Is Fair to Shareholders
09:59am, Friday, 10'th Jan 2025
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of ESSA Bancorp, Inc. (NASDAQ: ESSA) to CNB Financial Corporation for 0.8547 shares of CNB c
CNB Financial Corporation and ESSA Bancorp, Inc. Announce Strategic Merger
07:30am, Friday, 10'th Jan 2025
CLEARFIELD, PA and STROUDSBURG, PA, Jan. 10, 2025 (GLOBE NEWSWIRE) -- CNB Financial Corporation (Nasdaq: CCNE) (“CNB”), parent company of CNB Bank, and ESSA Bancorp, Inc. (Nasdaq: ESSA) (“ESSA�
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024
07:00am, Tuesday, 17'th Dec 2024
Company has initiated a process to explore and review strategic options focused on maximizing shareholder value SOUTH SAN FRANCISCO, California and VANCOUVER, Canada , Dec. 17, 2024 /PRNewswire/ - ES
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIX
07:23pm, Tuesday, 03'rd Dec 2024
NEW YORK , Dec. 3, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX). Such investors are advised to cont
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIX
12:00pm, Wednesday, 27'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ:EPIX). Such investors are advised to
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIX
04:30pm, Tuesday, 26'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 26, 2024 / Pomerantz LLP is investigating claims on behalf of investors of ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ:EPIX). Such investors are advised to
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIX
08:05pm, Monday, 25'th Nov 2024
NEW YORK , Nov. 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX). Such investors are advised to conta
ESSA Bancorp, Inc. Declares Quarterly Dividend
04:31pm, Wednesday, 20'th Nov 2024
STROUDSBURG, PA / ACCESSWIRE / November 20, 2024 / ESSA Bancorp, Inc. (NASDAQ:ESSA), the holding company for ESSA Bank & Trust, today announced that its Board of Directors declared a dividend of fifte
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIX
04:30pm, Wednesday, 20'th Nov 2024
NEW YORK CITY, NY / ACCESSWIRE / November 20, 2024 / Pomerantz LLP is investigating claims on behalf of investors of ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ:EPIX). Such investors are advise
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIX
09:52pm, Monday, 18'th Nov 2024
NEW YORK , Nov. 18, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX). Such investors are advised to co
ATTENTION ESSA Pharma Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
07:31pm, Saturday, 16'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of ESSA Pharma Inc. ("ESSA Pharma Inc.") (NASDAQ:EPIX) concerning possible vi
Sign In
Buy ESSA